Liquidia
14.21
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Liquidia
Liquidia Corporation, una empresa biofarmacéutica, desarrolla, fabrica y comercializa varios productos para las necesidades no satisfechas de los pacientes en los Estados Unidos. Sus productos candidatos incluyen YUTREPIA, una formulación de polvo seco inhalado de treprostinil para el tratamiento de la hipertensión arterial pulmonar. También distribuye inyecciones genéricas de treprostinil en los Estados Unidos. Liquidia Corporation se fundó en 2004 y tiene su sede en Morrisville, Carolina del Norte.
Trade GPT
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.